Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evogene (EVGN) Non-Current Deffered Revenue (2016 - 2019)

Historic Non-Current Deffered Revenue for Evogene (EVGN) over the last 4 years, with Q4 2019 value amounting to $9000.0.

  • Evogene's Non-Current Deffered Revenue fell 6785.71% to $9000.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $9000.0, marking a year-over-year decrease of 6785.71%. This contributed to the annual value of $9000.0 for FY2019, which is 6785.71% down from last year.
  • Per Evogene's latest filing, its Non-Current Deffered Revenue stood at $9000.0 for Q4 2019, which was down 6785.71% from $28000.0 recorded in Q4 2018.
  • Evogene's 5-year Non-Current Deffered Revenue high stood at $138000.0 for Q4 2016, and its period low was $9000.0 during Q4 2019.
  • In the last 4 years, Evogene's Non-Current Deffered Revenue had a median value of $58500.0 in 2017 and averaged $66000.0.
  • Its Non-Current Deffered Revenue has fluctuated over the past 5 years, first plummeted by 3550.72% in 2017, then tumbled by 6853.93% in 2018.
  • Over the past 4 years, Evogene's Non-Current Deffered Revenue (Quarter) stood at $138000.0 in 2016, then crashed by 35.51% to $89000.0 in 2017, then plummeted by 68.54% to $28000.0 in 2018, then plummeted by 67.86% to $9000.0 in 2019.
  • Its last three reported values are $9000.0 in Q4 2019, $28000.0 for Q4 2018, and $89000.0 during Q4 2017.